Symposium on bioequivalence studies

The symposium titled “A General Overview of Bioequivalence Studies” was organized by Istanbul Medipol University School of Pharmacy to share current information on bioequivalence studies and discuss scientific developments in this field. The opening speeches of the event held in the South Campus Conference Hall were made by Istanbul Medipol University School of Pharmacy Dean Prof. Gülden Omurtag and Symposium Chair Prof. Seda Ünsalan. The symposium, which brought together academics, representatives of contract research organizations, and pharmaceutical industry stakeholders, provided an opportunity to share the latest information on bioequivalence studies and discuss scientific developments.

PROF. OMURTAG: BIOEQUIVALENCE IS CRITICAL TO DRUG SAFETY 
In her opening speech, Prof. Gülden Zehra Omurtag emphasized that bioequivalence studies play a critical role in terms of drug safety and efficacy. Noting that these studies are of great importance in the process of determining whether generics are equivalent to originator products, Prof. Omurtag said the symposium brings together experts from various disciplines and paves the way for information exchange and new collaborations. Emphasizing that these studies have a direct impact not only on the scientific world but also on public health, Prof. Omurtag said: “In our symposium, we will discuss the latest developments, challenges, and future trends in bioequivalence studies. The exchange of knowledge and experience among our valuable participants from various disciplines will increase our knowledge base in this field and open the door to new collaborations.”